The zebrafish (Danio rerio) has emerged as an ideal organism for the study of hematopoiesis, the process by which all the cellular elements of the blood are formed. These elements, including erythrocytes, granulocytes, monocytes, lymphocytes, and thrombocytes, are formed through complex genetic signaling pathways that are highly conserved throughout phylogeny. Large-scale forward genetic screens have identified numerous blood mutants in zebrafish, helping to elucidate specific signaling pathways important for hematopoietic stem cells (HSCs) and the various committed blood cell lineages. Here we review both primitive and definitive hematopoiesis in zebrafish, discuss various genetic methods available in the zebrafish model for studying hematopoiesis, and describe some of the zebrafish blood mutants identified to date, many of which have known human disease counterparts.
INTRODUCTION
Once known as merely a tropical fish pet, the zebrafish (Danio rerio) has now developed into a powerful vertebrate model for the study of hematopoiesis and other aspects of embryogenesis and organogenesis (2, 12, 21, 23, 79, 88) . Unlike mammals, zebrafish eggs are fertilized externally and are readily available for observation or manipulation beginning at the single-cell embryo stage. The embryos are optically clear, so the entire organism can be easily evaluated under a dissecting microscope, including direct visualization of the beating heart and blood cells circulating in the vasculature. These small animals reach sexual maturity in only 3 to 4 months, and adult females are capable of producing 100 to 200 eggs weekly. Many thousands of animals can be kept in a fish facility requiring much less space than mice or other mammals, and hence the zebrafish is a cost-effective experimental vertebrate model for large-scale genetic screening (reviewed in 61) . Although invertebrate models have been invaluable in the study of embryogenesis, these organisms are not useful for the study of hematopoiesis or the function of mature blood cells. Using the zebrafish, several large-scale forward genetic screens in the past decade have generated thousands of mutants, many with hematopoietic defects that have enhanced the understanding of all aspects of hematopoiesis (67, 81).
PRIMITIVE (EMBRYONIC) HEMATOPOIESIS
All vertebrates, including bony fish (teleosts), have two waves of hematopoiesis (1, 2, 27, 91) . The earlier of these is known as the primitive or embryonic hematopoietic wave, and predominantly produces erythrocytes, as well as some primitive macrophages. In mammals and birds, this first hematopoietic wave is found in the extraembryonic yolk sac where early erythrocytes are generated. In zebrafish, primitive hematopoiesis occurs in two intraembryonic locations: the intermediate cell mass (ICM) located in the trunk ventral to the notochord, and the rostral blood island (RBI) arising from the cephalic mesoderm (1, 17) . Within the posterior mesoderm, cells lateral to the developing somites express both vascular and blood markers and migrate medially around 18 h post fertilization (hpf) to fuse at the midline forming the ICM (Figure 1) . Cells within the ICM, equivalent to the mammalian yolk sac blood island, differentiate into the endothelial cells of the trunk vasculature and proerythroblasts, which begin to enter the circulation around 24 hpf. Concurrent with the primitive erythropoietic wave in the posterior ICM, cells in the anterior mesoderm of the zebrafish embryo make up a second anatomical site for hematopoiesis, known as the RBI, which predominantly generates macrophages (discussed below).
Primitive Progenitors in the ICM
As primitive hematopoietic progenitors begin to differentiate within the ICM, they express transcripts of several transcription factors. The zebrafish homologues have been identified for many mammalian transcription factors known to regulate hematopoiesis in primitive progenitor cells. The stem cell leukemia (scl) gene encodes a basic helix-loophelix transcription factor, found to be expressed by 10 hpf in the posterior mesoderm of the zebrafish embryo (46, 64) . Its expression marks the formation of primitive HSCs and also vascular precursors, known as angioblasts. Numerous other transcription factors are also expressed by these early blood Table 1) . At this time, it is controversial whether a true bipotential "hemangioblast" precursor cell exists, or whether parallel populations of angioblasts and primitive HSCs in the posterior mesoderm develop independently (2, 22, 60) .
Primitive Erythropoiesis
Gata-1, a zinc finger transcription factor, is critical for primitive erythropoiesis. First expressed in a subset of scl + cells in the zebrafish embryo around 5 somites (approximately 12 hpf), gata-1 transcripts are expressed bilaterally in the lateral plate mesoderm that will migrate medially to form the ICM (18, 72) . The number of gata-1 + erythroid precursors increases as they migrate towards the midline, and by the time the ICM is fully formed, approximately 300 cells with morphology reminiscent of proerythroblasts can be found in the ICM. Transgenic zebrafish carrying the gata-1 (52) . Once mature, the erythrocytes develop a characteristic flattened elliptical shape and retained nucleus. These "primitive" erythrocytes are morphologically distinct from adult zebrafish erythrocytes, which have less cytoplasm and a large elongated nucleus. In contrast, whereas primitive mammalian erythrocytes are nucleated as well, mammalian adult erythrocytes do not retain their nuclei. Transfusion experiments using rhodaminelabeled circulating erythrocytes showed these primitive erythrocytes are the only circulating erythroid cells for the first 4 dpf (81). The donor cells are taken at 36 hpf from rhodamine-labeled embryos and injected into the sinus venosus of the recipient embryos.
The donor cells in circulation do not start to decline until 6 dpf. Although the lifespan of these primitive erythrocytes is not known, by 10 dpf only 50% of the rhodamine-labeled donor cells remain within the unlabeled recipient host as the definitive erythrocytes begin to populate the circulation (81). These data indicate that the first circulating primitive erythrocytes are ultimately replaced by new erythroid cells that develop later.
As the primitive erythroblasts enter the circulation and mature, they express erythroidspecific genes necessary for hemoglobin synthesis, including α and β embryonic globin chains, alas2, fch, and urod ( Table 1) . They also express DMT1, which is important for iron uptake, and scaffolding proteins such as β-spectrin and protein 4.1R, which ensure membrane stability. Zebrafish with mutations in these genes have red blood cell anomalies analogous to many human red blood cell diseases ( Table 2) .
Embryonic Myelopoiesis
Like the primitive progenitors in the ICM, those found in the RBI contribute to both blood and vascular development, and express similar transcription factors, including fli1a, gata2, lmo2, and scl (9, 46, 72) (Figure 1) . The function of these early macrophages has been observed as early as 26 hpf in the ducts of Cuvier, where macrophages can be observed engulfing apoptotic erythroid cells (35) . These macrophages express l-plastin and are distributed throughout the embryo by 28-32 hpf. Primitive immune function of macrophages is also evident as they migrate to the site of an infection with Escherichia coli or Bacillus subtilis and phagocytose the offending organisms (35) , or can clear microinjected carbon particles from the circulation as early as 2 dpf (50).
Driving Progenitor Cell Fate Within the ICM
The balance between primitive erythroid and myeloid cell production is a delicate one, governed predominantly by the equilibrium of gata-1 and pu.1 expression within the ICM. Galloway et al. showed that loss of gata-1 expression in living zebrafish embryos resulted in transformation of erythroid precursors into myeloid precursors, with resulting myeloid expansion at the expense of total number of erythroid cells (26). In gata-1 −/− embryos, pu.1 expression persists longer in the ICM than seen in wild-type embryos, suggesting that gata-1 normally functions in part to limit pu.1 expression by these cells. In contrast, other early markers of hematopoiesis including scl, lmo-2, gata-2, c-myb and ikaros, all have normal expression in the gata-1 −/− embryos. The early ICM blood precursors in the gata-1 −/− embryos are converted into myeloid cells, an indication that gata-1 acts both to promote erythroid development and also to suppress myeloid cell fate decisions (26).
DEFINITIVE (ADULT) HEMATOPOIESIS AND DEFINITIVE HSCs
By definition, definitive or adult hematopoiesis provides an organism with long-term HSCs capable of unlimited self-renewal and able to generate all mature hematopoietic lineages. In mammals, these HSCs are found in close association with the ventral wall of the dorsal aorta in a region known as the aorta-gonad-mesonephros (AGM), later transitioning to the mammalian fetal liver and the bone marrow (27, 91). The AGM equivalent in zebrafish is also found in the ventral wall of the dorsal aorta where several markers of HSCs are expressed between 24-48 hpf. While expression of gata-1, gata-2, and scl is waning in the ICM, expression of c-myb (72) and runx1 (13, 42, 43) is noted in the AGM, marking cells believed to be the first definitive HSCs in these animals ( Figure 2) . In mice and zebrafish, Runx1 is a transcription factor essential for HSC formation in the AGM (13, 42, 43, 59 ). In the zebrafish, runx1 transcripts are detected as early as 24 hpf, although it is uncertain at what time point these cells enter the circulation (13, 42, 43) . Other transcription factors including c-myb, ikaros, lmo-2, and scl are also expressed in the AGM (72).
Around 4-5 days post fertilization (dpf), the location of blood formation shifts to the kidney in the zebrafish embryo as lifelong definitive hematopoiesis is established (27, 85). The AGM progenitors are believed to be the precursors of these definitive HSCs, which ultimately seed the embryonic kidney marrow, although lineage tracing has not yet been completed. In the adult zebrafish, hematopoietic cells are found intercalated between the renal tubules in the kidney marrow, much like mammalian adult hematopoiesis that takes place in and around the fat and stroma of the bone marrow. Cytospin preparations of the kidney marrow reveal that all the circulating hematopoietic blood cell types are present (Figure 3) . Flow cytometry of these kidney marrow cells allows cell separation by forward scatter (indicative of cell size) and side scatter (indicative of granularity). This method has enabled development of a zebrafish hematopoietic stem cell transplantation model to facilitate further study of definitive HSCs in the zebrafish (74).
Definitive Erythropoiesis
The second wave of erythropoiesis is postulated to begin around 5 dpf, as the bloodless mutant (discussed below) with a defect in ICM erythropoiesis has recovery of circulating red blood cells around this stage (48) . The process of erythropoiesis is very similar in mammals and nonmammalian vertebrates, although there are morphological differences between mature erythrocytes of these two groups. While erythroid precursors are very similar, the terminally differentiated mammalian red blood cells have a classic biconcave discoid shape and do not retain their nuclei, and the nonmammalian mature red blood cells are nucleated and elliptical in shape (Figure 3) . Like other higher vertebrates, zebrafish express hemoglobin with a quaternary structure (α 2 β 2 ), and they undergo globin switching from primitive embryonic globin chains to the adult globin chains (11, 14) . 
MPO: myeloperoxidase

PAS: periodic acid Schiff
Granulopoiesis
Zebrafish have two granulocyte lineages, one that is similar to mammalian neutrophils, and the other a unique cell type bearing characteristics of both mammalian eosinophils and basophils (8, 16, 50) . Both human and zebrafish neutrophils stain positively for myeloperoxidase (MPO) and acid phosphatase, although morphologically zebrafish neutrophils are slightly different from their human counterparts in that the nuclei of zebrafish neutrophils have only two or three segments compared with the four or five segments found in human cells (Figure 3) . Zebrafish eosinophils have a very granular cytoplasm, but do not possess the bilobed nucleus seen in human eosinophils (Figure 3) . Their granules are peroxidase negative and periodic acid-Schiff (PAS) positive, and structurally are most like the granules in mammalian basophils and mast cells (8, 16, 50).
As discussed above, the first granulocytes are identified by their expression of the granulocyte-specific marker, mpo in the posterior ICM and migrating across the anterior yolk around 18-20 hpf (8, 50). It is not known whether the granulocytes found in the pronephros by day 7 are these same primitive mpo + granulocytes or whether they represent a second wave of granulopoiesis (85). Granulocyte function in zebrafish is evident by migration of mpo + cells to a site of injury, such as tail clipping (50 
Lymphopoiesis
Like mammals and other vertebrates, zebrafish possess an adaptive immune system complete with B cells expressing immunoglobulins and T cells expressing rearranged antigen-specific T cell receptors (45, 75) . T cell maturation takes place in the zebrafish thymus, as it does in mice and humans. Bilateral thymic primordia form as outgrowths of pharyngeal epithelium between the third and fourth pharyngeal pouches and are first populated by immature lymphoblasts around 65 hpf (85). The derivation of the lymphoid progenitors that populate the thymus is not known. Given the timing when these cells appear, their progenitors must not originate in the kidney marrow, because HSCs are not yet found there until 5 to 6 dpf. A subset of the ikaros + cells in the AGM at 48 hpf are likely candidates for these lymphoid progenitors that ultimately seed the thymus (86).
The thymus continues to grow over the next several days such that by 7 dpf numerous small, mature lymphocytes populate the thymic epithelium (85). Characteristic T cell gene expression is observed around 3-4 dpf including gata3, ikaros, the T cell receptor kinase lck, and the recombination activating genes rag-1 and rag-2, which are required for rearrangement of T cell receptor genes and also immunoglobulin genes in immature lymphocytes (84).
B cell development is established in the pronephros by 19 dpf (17, 44) . Antibodies against classical T and B cell markers, such as CD2, CD3, CD19, CD20, and surface immunoglobulin and T cell receptors, do not exist for the zebrafish. As such, tracking of developing B and T cell populations within the zebrafish is difficult. Experiments using transgenic zebrafish, which express GFP (green fluorescent protein) driven by either the rag2 or lck promoters, enabled fluorescent tracking of immature B and T lymphocytes, and mature T cells, respectively (44) . These experiments confirmed that B cell development occurs in the kidney marrow and T cells develop exclusively in the thymus.
Thrombopoiesis
Zebrafish thrombocytes are nucleated blood cells equivalent to mammalian platelets, which function to maintain hemostasis by facilitating clot formation (37) . Adhesion and aggregation of thrombocytes in response to ristocetin, collagen, thrombin, ADP, and arachidonic acid are similar to the activation of mammalian platelets by these agonists (37) . In addition, polyclonal antisera against human platelet markers GpIIb/IIIa and GpIb are reactive with zebrafish thrombocytes, supporting the hypothesis that these surface glycoproteins important for platelet function have conserved expression on teleost thrombocytes (37) . Despite functional similarity with mammalian platelets, the ontogeny of zebrafish thrombocytes is not well understood. Circulating thrombocytes are identified in zebrafish embryos as early as 36 hpf (30), although their precursors have not yet been discovered. In mammals, multinucleated giant cells called megakaryocytes are found in the bone marrow and are known to be the precursors of platelets. While no similar precursor cell has been identified in zebrafish, many of the mammalian transcription factors important for megakaryocyte development have also been identified in zebrafish, including  fli1, fog1, gata1, nfe2, and runx1 (13, 65, 69, 72 ). Further studies are needed to identify the thrombocyte precursors and the location of thrombopoiesis in the zebrafish.
GENETIC METHODS FOR STUDYING HEMATOPOIESIS IN ZEBRAFISH
The zebrafish has numerous advantages that make this organism particularly amenable to the study of hematopoiesis. The externally fertilized, optically clear embryos are easily observed and manipulated. Morphologic mutants are readily identified, including easy identification of blood mutants, as circulating blood cells are visible in embryos. Diffused oxygen in the fish water provides sufficient oxygenation for several days post fertilization. As such, anemic zebrafish mutants with few or no blood cells survive long enough for their mutant phenotype to be detectable. Several genetic methods are described below that take advantage of these characteristics of the zebrafish model.
Mutagenesis Screening
The first large-scale genetic screens in a vertebrate organism were performed using zebrafish in Boston, Massachusetts, and in Tübingen, Germany (23, 31). These screens utilized visual inspection to identify hundreds of mutant zebrafish embryos and early larvae. To perform this type of screen, adult male fish are exposed to ethylnitrosourea (ENU), which mutagenizes the DNA within the premeiotic germ cells (spermatogonia) (Figure 4) . These fish are then mated to normal unmutagenized female fish. The resulting F 1 generation contains heterozygotes for mutations in genes within the zebrafish genome, at a rate of approximately 100 to 200 mutations per fish. The F 1 fish are mated to wild-type fish again and the resulting F 2 fish families are incrossed in order to identify the heterozygous carriers of the mutant genes.
Using this method, scores of mutant zebrafish alleles were identified affecting the de- Schematic of a large-scale ENU mutagenesis screen. Adult male zebrafish are treated with ENU, which generates point mutations in the DNA of the spermatogonia. ENU-treated males are crossed with wild-type females to produce the F 1 generation. Heterozygous F 1 progeny are mated with wild-type fish to create F 2 families, in which half the siblings are heterozygous for a specific mutation (m) and the other half are wild type. Random sibling incrosses result in F 3 progeny. When two heterozygous F 2 siblings are crossed, the resulting F 3 clutch will contain 25% wild-type fish (+/+), 50% heterozygous fish (+/m) and 25% homozygous mutant fish (m/m) with a specific mutant phenotype. identified, the gene causing the phenotype can be mapped to a specific zebrafish chromosome (7). Such mapping endeavors have been markedly simplified since the sequencing of the zebrafish genome and the development of zebrafish genomic libraries (3). Haploid and gynogenetic diploid zebrafish embryos allow more efficient screening for mutant progeny, and these methods have also been successfully implemented for zebrafish screens (reviewed in 61). Insertional mutagenesis using a retroviral vector also allows genomic mutagenesis and facilitates cloning of the disrupted gene (4, 5, 29). However, the efficiency of mutagenesis is at a substantially lower frequency per genome, approximately 10% the rate observed with chemical mutagenesis.
Morpholinos
"Knockdown" of mRNA for specific genes of interest can be achieved in zebrafish by the use of morpholinos, specific anti-sense RNA oligomer sequences (57) . These oligomers are modified to prevent degradation in the cell. As such, they persist for 1 to 3 days when microinjected into the fertilized onecell embryo, and act to inhibit RNA translation and/or splicing of the specific sequence of interest by targeting the translation initiation site or splice sites. While highly specific, these morpholinos are short-lived and their injection can produce dose-dependent toxicity (32). An example of this powerful method is outlined by Dooley et al., who used scl morpholinos to show that knockdown of scl resulted in loss of primitive and definitive hematopoietic cell lineages, without losing the specification of early angioblasts (22) .
Transgenic Reporters
Transgenic mouse models have been a mainstay of genetic studies. Microinjection of DNA constructs into single-cell fertilized zebrafish embryos has proven successful in the generation of transgenic zebrafish. The widespread use of fluorescent proteins in mammalian systems has been successfully adapted for use in zebrafish, which are wellsuited to the use of fluorescence because of their optical clarity and external development. By linking a fluorescent protein such as GFP or DsRed to a gene or promoter of interest, expression can be easily visualized in living animals. Transgenic reporter vectors with a constitutive or tissue-specific promoter (for example, the gata-1 promoter for erythroid cells) linked to a fluorescent reporter gene enable fish to express fluorescent proteins, which are easily visible under the microscope in these transparent embryos. To study erythroid cells, GFP was placed under control of the gata-1 promoter (52). These fish have erythroid-specific GFP expression by 16 hpf. Stable transgenic fish can be generated from the progeny, as 1%-5% of injected embryos will integrate the transgene into the germline DNA. Tissuespecific expression of the recombinating activating gene (rag-1) promoter driving GFP expression has aided the understanding of lymphoid development in zebrafish (38, 39, 44) . Vascular and hematopoietic tissues are visualized in vivo with double transgenic embryos expressing an lmo2:DsRed transgene as well as gata1:GFP (see Figure 5 ) (89, 90). Fluorescent transgenic fish have proven to be useful tools for cell fate mapping and also for hematopoietic stem cell transplantation experiments (44, 74) , but the applications are virtually endless as new promoters are discovered and different cell types can be studied.
TILLING
Targeted Induced Local Lesions In Genomes (TILLING) is a reverse genetics method for high-throughput screening for mutations in specific genes of interest (82, 83). This procedure has been successfully used to identify target-selected mutants in numerous species including plants, Drosophila, Caenorhabditis elegans, rats, mice, and zebrafish. Much like ENU mutagenesis for forward genetic screens, this strategy involves random chemical mutagenesis of male animals, which are mated to wild-type females to generate a large population of F 1 animals. The F 1 males are sacrificed to generate matched libraries of genomic DNA for screening and cryopreserved sperm samples to recover lines of interest. An alternate approach is to screen tail clip DNA from live F 1 fish kept in isolation or in small pools. DNA from the F 1 males is amplified using nested PCR and sequenced to identify mutations in a specific gene of interest. Cryopreserved sperm from identified mutant animals is then used for in vitro fertilization so that the mutant phenotype can be recovered and studied. This technique was utilized to identify 15 different mutations in the rag-1 gene (82). By identifying many mutants of a single gene, partial knock-out of that gene can be observed, critical signaling domains can be characterized, and downstream signals can be elucidated.
ZEBRAFISH MUTANTS AS MODELS FOR HUMAN BLOOD DISEASES
Large-scale forward genetic chemical mutagenesis screens in zebrafish have generated many zebrafish mutants with interesting developmental phenotypes (23, 31), some of which mirror human diseases ( Table 2) . More than 40 mutants with hematopoietic defects, consisting of 26 complementation groups, were identified in the large-scale mutagenesis screens in Boston and Tübingen in the mid1990s (67, 81). These mutants were initially identified by gross observation of decreased blood circulating in early embryos and were later characterized by whole mount in situ hybridization studies to assess expression of known hematopoietic transcription factors including gata-1 and scl. The blood mutant phenotypes can be divided into several subcategories: those with no red blood cells (bloodless mutants), progressive anemia, hypochromic anemia, or photosensitivity (67). 
Bloodless Mutants
Several zebrafish mutants identified possess defects in the development of erythroid progenitor cells. Moonshine (mon) zebrafish mutants fail to express gata-1 normally, and they have a severe anemia resulting from disruption of both the primitive and definitive waves of hematopoiesis (66) . This mutation is a noncomplementing allele of the vampire gene, also identified in a forward genetic screen (81). By 5 to 7 dpf, the mon embryos have only 5%-10% of the circulating cells that are found in wild-type embryos (66) . While wildtype animals have 1000-3000 circulating nucleated erythrocytes, mon mutants have only 50-100 circulating cells and no detectable hemoglobin, as measured by staining with o-dianisidine (67). The few rare circulating cells that are seen have a proerythroblast morphology, suggestive of a differentiation blockade in the mon mutants. Most of these severely anemic animals do not live past 10 to 14 dpf,
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although rare homozygous mon mutant animals survive to adulthood (66) . These adult mutants have marked cardiomegaly due to severe anemia and the resulting state of high cardiac output. Further characterization of the mon mutant reveals severely decreased expression of gata-1 and gata-2, along with normal expression of markers for lymphoid and myeloid cells, data that also support a specific block in early red blood cell differentiation. Ultimately, positional cloning revealed the mon gene encodes the zebrafish orthologue of the mammalian transcriptional intermediary factor 1γ (TIF1γ ), a transcription factor that plays a critical role in early erythroid differentiation (66) .
As discussed above, gata-1 is another transcription factor that plays an important role in erythropoiesis. Through positional and candidate gene cloning, gata-1 was identified as the truncated mutant gene responsible for the bloodless phenotype of the vlad tepes (vlt) zebrafish mutant (53) . Until 24 hpf, these embryos have normal expression of lmo-2, scl, and cbfb, all markers of early hematopoietic progenitors. Normal development of myeloid and lymphoid lineages is also noted, as measured by expression of pu.1, l-plastin and c/ebp1, and ikaros and rag-1, respectively. Intact expression of stem cell, myeloid, and lymphoid markers indicates normal development of these cell types in the vlt mutants (53) . Despite the presence of normal hematopoietic progenitors, the lack of functional gata-1 makes these cells unable to differentiate down the erythroid lineage.
The bloodless (bls) zebrafish mutant embryos have virtually no circulating red blood cells until approximately 5 dpf when hemoglobinized cells begin to appear, coincident with the onset of definitive hematopoiesis (48) . Originally isolated as a spontaneous mutation, bls is inherited in an autosomal dominant fashion with incomplete penetrance. As such, the phenotype varies from a complete absence of primitive erythrocytes to very severe early anemia. Kidney marrow hematopoiesis appears normal in the bls adult animals, demonstrating that only primitive hematopoiesis is affected. Cell transplantation experiments demonstrate that bls mutant donor cells were unable to contribute to gata-1-expressing cells of the ICM in wildtype recipients (48) . In addition, wild-type donor cells could not differentiate into gata-1-expressing cells in the ICM of bls recipients (48) . While the bls gene has not yet been identified, the non-cell autonomous nature of bls function suggests that this may be a secreted factor.
Mutants with Progressive Anemia
Several of the red blood cell mutants identified have defects resulting in a decreasing number of blood cells after apparently normal blood development in the first 2 dpf. Examples in this group include cabernet (cab), chablis (cha), grenache (gre), merlot (mot), riesling (ris), retsina (ret), and thunderbird (tbr) (67, 81). These mutants all initiate hematopoiesis normally and in the first few days of life are difficult to distinguish from their wild-type siblings. They initially have normal expression of gata-1, typically pigmented blood, and staining with o-dianisidine. They begin to develop anemia around 2 to 4 dpf, suggesting that these mutations affect erythroid cell expansion or stability of the mature red cells.
Mutations of cytoskeletal proteins.
The mot and cha mutants, now known to bear mutations in the same gene, have normal onset of primitive hematopoiesis and later develop anemia around 4 dpf (70). Morphologically, these erythrocytes are noted to have spiculated membranes and bi-lobed nuclei. At 24 hpf, mot/cha homozygotes exhibit normal expression of gata-1, scl, and embryonic globin, indicating that while erythropoiesis remains intact, the abnormal mature red blood cells are hemolyzed. A small percentage of homozygous mot animals survive to adulthood when raised with frequent feeding and an abundant level of oxygen in the water. These fish have significant anemia and their red blood cells are arrested in the basophilic erythroblast stage. The erythrocytes of adult homozygous animals have bizarre membrane projections and increased osmotic fragility, suggestive of certain human hemolytic anemias, which also result from increased osmotic fragility. In fact, using positional cloning and candidate gene cloning methods, the mot and cha mutations were found to reside in the gene encoding erythrocyte protein 4.1 (also called band 4.1 or 4.1R), a structural membrane protein expressed in red blood cells that binds to spectrin and anchors the spectrin-actin cytoskeleton to the erythrocyte cell membrane (70). Deficiency of protein 4.1 in humans causes hereditary elliptocytosis, a rare cause of hemolytic anemia characterized by elliptical-shaped red blood cells (76, 77).
β-spectrin, another critical membrane protein in erythrocytes, is one of the most abundant components of the erythrocyte cytoskeleton (76). Using comparative genomics, the zebrafish mutant ris was found to have a null mutation in the erythroid β-spectrin gene (47) . By 4 dpf, homozygous ris mutants are severely anemic. The ris erythrocytes are abnormally shaped with large nuclei, as opposed to the characteristic elliptical shape of adult zebrafish erythrocytes. These cells are reminiscent of those seen in the human erythroid disorder hereditary spherocytosis (HS), which results from mutations in human β-spectrin (24). Adult ris zebrafish have an increased number of hematopoietic progenitors in the kidney marrow, analogous to the increased number of red cell progenitors in the bone marrow of humans with HS.
Similar to the mot/cha and ris mutants, the zebrafish mutant ret becomes anemic around 4 dpf, shortly after the onset of definitive hematopoiesis. Unlike these other mutants with membrane protein abnormalities, the circulating mature erythrocytes in the ret mutants are arrested at the erythroblast stage, and a large proportion (approximately 27%) have two nuclei (63) , suggestive of a defect in cytokinesis. This phenotype is suggestive HS: hereditary spherocytosis of the human disorder known as congenital dyserythropoietic anemia type II (33, 34, 62, 63) . Evaluation of the ret mutants revealed that band 3 is the mutant gene responsible for this phenotype (62, 63) . Band 3 was demonstrated to play a critical role in chromosomal segmentation during anaphase, such that lack of band 3 prevented cytokinesis in zebrafish erythroblasts (62, 63) . This result is similar in mice as well, indicating conservation of function across phylogeny. Other proteins important in humans for red blood cell structure, including ankyrin and erythroid α-spectrin,
have not yet been identified among zebrafish mutants.
Hypochromic Mutants
The hypochromic zebrafish mutants have abnormally small (microcytic) erythrocytes with pale cytoplasm (hypochromia) indicative of a decreased level of hemoglobin. Since the production of hemoglobin is a complex, multifaceted process, there are numerous aspects of hemoglobin biosynthesis that can go awry. Examples of zebrafish mutants in this category include chardonnay (cdy), chianti (cia), frascati (frs), gavi (gav), montalcino (mnt), sauternes (sau), shiraz (sir), weissherbst (weh), and zinfandel (zin) (67, 81).
The sau hypochromic mutation was found to map to the δ-aminolevulinate (ALAS2) gene, known for its importance in the heme biosynthetic pathway (10). The sau mutant mimics the human disease congenital sideroblastic anemia, which consists of anemia secondary to reduced heme synthesis, and cellular toxicity from elevated iron levels (68). The sau zebrafish mutant represents the first animal model of this disease. In the zebrafish sau mutants, primitive erythrocytes differentiate abnormally such that embryos have decreased heme and β-globin levels by 2 dpf.
The zin zebrafish mutation maps to the zebrafish major globin locus of chromosome 3, and as such, this hypochromic mutant may represent a disorder similar to the thalassemias seen in humans where the www.annualreviews.org • Blood Development in Zebrafishexpression of globin chains is unbalanced (11). When either the α-globin or β-globin protein is markedly decreased, the excess globin chains precipitate within the erythrocyte, leading to generally profound anemia (24). It is postulated that the zin mutation may lie within the locus control region of the zebrafish globin gene cluster, thereby resulting in decreased globin expression. Since the zebrafish α-and β-globin loci are located in the same chromosome, unlike the human globin genes, the zin mutant may be slightly different from the classic human thalassemia where globin chain expression is unbalanced. Mapping of the zin mutant gene is currently under way, and will help clarify the understanding of hypochromic anemias.
Defects in iron metabolism. Iron metabolism is an essential component of heme synthesis, and hence defects in its absorption, storage and trafficking can lead to hypochromic anemias in humans. Another hypochromic mutant, weh, has decreased mean corpuscular hemoglobin levels but a nearly normal total number of red blood cells. This mutation has been mapped to the ferroportin 1 gene, which encodes a novel iron transporter (20, 25) . Mouse and human orthologues for ferroportin 1 have been cloned and the iron transporter appears to have conserved function in vertebrates. Mutations in this gene have been identified in patients with hemochromatosis type IV (56, 58) .
The cdy zebrafish mutation is an autosomal recessive allele resulting in delayed anemia similar to the sau and weh mutants. These embryos have a normal number of circulating erythrocytes until approximately 48 hpf, at which time they are noted to have hypochromic, microcytic erythrocytes with abnormal, less-condensed nuclei, indicative of immaturity. The cdy cells have normal expression of globin genes. Positional cloning and candidate mapping strategies identified the iron transporter gene DMT1 as the mutant gene (19) . In vertebrates, divalent metal transporter1 (DMT1) conveys ferrous iron from the gut into the duodenal enterocyte, while the iron transporter ferroportin 1 transports iron across the basolateral membrane of the enterocyte into the circulation (71). Transport of iron from the endosome into the cytosol requires DMT1, and thereby allows the iron to be available to the cell for incorporation into hemoglobin (6, 40).
Another of the hypochromic zebrafish mutants, cia, also appears related to iron metabolism. This mutation is homozygous viable in the adult fish and results in a hypochromic anemia first evident around 36 hpf by staining with o-dianisidine (87). The animals survive into adulthood without growth retardation or cardiomegaly; however, the circulating erythrocytes of adult cia zebrafish are hypochromic and microcytic, and the kidney marrow of these fish is hypercellular, with an increased proportion of erythroid progenitors (87). Using a candidate cloning strategy, Wingert et al. showed that cia zebrafish have a mutation in the transferrin receptor 1 gene (tfr1a). Exclusively expressed by zebrafish erythrocytes, tfr1a is critical for iron acquisition by these cells. By injecting singlecell fertilized embryos with iron-dextran, the hypochromia of cia mutants can be rescued, while intravenous iron-dextran injection at 48 hpf fails to rescue the hypochromic phenotype (87). A second transferrin receptor orthologue identified in zebrafish, tfr1b, is expressed in many cell types throughout embryogenesis. Overexpression of tfr1b is sufficient to compensate for the lack of tfr1a in the cia mutants, although it appears the tfr1b orthologue is primarily utilized by nonhematopoietic tissues (87).
Photosensitive Mutants
Photosensitive blood mutants result in erythrocytes that autofluoresce and lyse when exposed to ambient light, a phenotype analogous to the human congenital erythropoietic porphyrias. Examples of these photosensitive mutants include dracula (drc), desmodius (dsm), freixinet (frx), and yquem (yqe).
Mutations in the yqe gene result in a porphyria syndrome characterized by autofluoresence under UV light, and photoablation of erythrocytes when subjected to light exposure. The porphyria syndrome in humans is due to defects in heme biosynthesis. Using porphyrin and enzymatic assays, uroporphyrinogen decarboxylase (UROD) was identified as the enzymatic deficiency in the yqe zebrafish mutants (78). This proved to be the first animal model for hepatoerythropoietic porphyria, the human disease equivalent (68).
drc is another zebrafish mutant with a photosensitive phenotype. By 4 dpf, these embryos lack all red blood cells when raised under normal lighting conditions. Their red blood cells exhibit strong fluorescence. Like the human disorder erythropoietic protoporphyria, which manifests as light-dependent hemolysis of red blood cells in combination with liver disease, the drc mutant fish have an accumulation of protoporphyin IX (68). This was suggestive of a deficiency in ferrochelatase, which in fact turned out to be the defective enzyme in these mutants (15) .
SUMMARY POINTS
1. The zebrafish serves as a unique model organism for the study of hematopoiesis, with many advantages over other vertebrate and invertebrate models.
2. Zebrafish orthologues have been identified for numerous mammalian transcription factors important for hematopoiesis.
3. As in other vertebrates, hematopoiesis in zebrafish occurs in two waves, the primitive or embryonic wave, and the definitive or adult wave.
4. Primitive hematopoiesis occurs in an intraembryonic location called the ICM, and generates predominantly primitive erythrocytes and some myeloid cells.
5. Definitive hematopoiesis occurs in the AGM and is marked by the expression of runx1 and c-myb around 24-48 hpf. By 5 dpf, definitive hematopoiesis has migrated to the zebrafish kidney marrow, where all hematopoietic cell types are produced during the lifespan of the animal.
6. Large-scale forward genetic screens have identified dozens of zebrafish blood mutations, many of which have now been cloned, and which represent animal models for known human diseases.
FUTURE DIRECTIONS
1. Identification of zebrafish analogues of mammalian genes has been facilitated by the sequencing of the zebrafish genome. New genes continue to be mapped.
2. Affymetrix zebrafish GeneChips allow the simultaneous expression analysis of approximately 14,900 zebrafish transcripts. Recently, differential gene expression profiling using these GeneChips was reported in various zebrafish blood mutants, revealing several novel hematopoietic and vascular genes (80). This tool has broad potential for future studies. 
